Gilead
RSS
Stories
Most Recent Most Popular Most Commented
Currently this sections has no news, Please try Again Later or help us in building this section
You can Submit Newslinks HERE
Stories
Most Recent Most Popular Most Commented
Currently this sections has no news, Please try Again Later or help us in building this section
You can Submit Newslinks HERE
Images
Palo Alto:

In this Jan. 28, 2009 file photo, the exterior of CV Therapeutics headquarters in Palo Alto, Calif. is shown. Biotechnology company Gilead Sciences Inc. said Thursday it will buy CV Therapeutics for about $1.4 billion as a wave of consolidation in the...

FAQ / Help
Move to top